Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral Neuropathy

NCT00229437 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

343

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathies

Interventions

DRUG: TAK-128
DRUG: TAK-128
DRUG: TAK-128
DRUG: Placebo

Sponsor

Takeda